Ruby Market Report — H1 2026

H1 2026 Performance Overview

Below are year-on-year price movements for the primary ruby segments (H1 2026 vs H1 2025), based on GRS-certified unheated specimens transacted in private sales:

The 15–18% gain in pigeon blood material substantially outperformed other real assets over the same period — the S&P 500 returned approximately 7% and spot gold approximately 6% in H1 2026. The structural supply-demand imbalance driving ruby prices is discussed in detail below.

Burma Ruby: The H1 Standout

Burma (Myanmar) ruby was the single best-performing major gemstone category in H1 2026 — and the structural reasons for that performance are not going away.

Supply side: Since the US, EU, and UK imposed sanctions on Myanmar's mining exports in 2021, the flow of newly mined, internationally certifiable Burma rubies has fallen sharply. The existing inventory of GRS-certified Burma material is finite and being absorbed faster than it can be restocked. Several dealers who previously relied on direct-from-Myanmar supply chains are now acquiring from private holders — itself a signal of scarcity.

Demand side: Demand is converging from multiple independent directions: traditional jewellery buyers, private collectors in Southeast Asia and the Middle East, and — increasingly — institutional-style alternative asset investors who specifically seek certified coloured stones as portfolio diversifiers. This last group places particular value on documentation, and their demand for the GRS pigeon blood designation has widened the premium further.

The H1 auction highlights underscore the trend. Christie's Geneva May sale featured a 9.2ct GRS pigeon blood Burma ruby that achieved over $580,000 ($63,000/ct), approximately 18% above comparable lots in the same sale one year prior. Sotheby's Geneva May sale included a 6.8ct pigeon blood example at $71,000/ct — setting a meaningful benchmark for private-market pricing of equivalent material.

The Pigeon Blood Premium: Structural, Not Cyclical

The GRS “pigeon blood” designation is one of the highest-returning single quality descriptors in the gemstone market. As of mid-2026, it commands a 2.5–3.5x premium over equivalent unheated Burma rubies of the same carat and clarity without the designation — up from approximately 2.0x in early 2025.

Why the premium widened: GRS defines pigeon blood as requiring a specific combination of colour (vivid to slightly purplish red within a defined saturation and hue range) and fluorescence (strong red fluorescence is a core marker). Very few stones qualify. As collectors and investors have become increasingly aware of this distinction, the pricing power of the “GRS pigeon blood” designation has grown — buyers know they are acquiring something genuinely scarce.

For buyers with the budget, GRS-certified pigeon blood Burma ruby represents one of the most liquid, premium-stable single assets in the coloured gemstone market. For investors working with tighter budgets, unheated Mozambique ruby provides a more accessible entry point with a credible growth track record.

Mozambique Ruby: The Accessible Entry Point

Mozambique's Montepuez deposit has established itself as the credible alternative to Burma material over the past five years. GRS certifies Mozambique origin to the same rigorous standard, and top-quality unheated Mozambique rubies can display saturation and tone comparable to fine Burma material. The price differential — meaningful but not a ceiling — reflects origin desirability rather than a quality gap.

The 9–11% YoY gain in fine Mozambique material in H1 2026 is driven by several factors: Montepuez production is relatively stable, making fresh GRS-certified supply more accessible; private-market liquidity is higher (more buyers and sellers); and the lower absolute price point attracts a wider investor base.

The caveat: the Burma–Mozambique origin premium is structural and will not disappear. For investors prioritising maximum long-term appreciation, Burma material is the first choice where accessible. For investors who want certified, liquid, appreciating gemstone exposure without the Burma price premium, quality unheated Mozambique ruby is a mature option.

H2 2026 Outlook: Auction Season and Price Catalysts

The key events that will define H2 ruby pricing:

• —Sotheby's Geneva, September: Confirmed to include two GRS pigeon blood Burma rubies, one exceeding 4ct. Results will set the H2 private-market benchmark and are expected to provide further upward price guidance.
• —Sotheby's Hong Kong, October: The Asian market window. Mainland Chinese, Taiwanese, and Southeast Asian buyer activity is expected to remain strong — this sale will reflect the real temperature of Asian demand for pigeon blood material.
• —Christie's New York, November: North American alternative-asset buyers have been increasing coloured stone allocation; this sale is a useful gauge of institutional-style demand velocity.

Risk factors: Any shift in Myanmar sanctions policy could alter supply expectations. A broad deterioration in global risk appetite would weigh on discretionary asset demand. Neither scenario appears likely in the near term, but both are worth monitoring. On balance, the structural case for Burma pigeon blood ruby appreciation through H2 2026 remains intact.

Pre-auction window: Historically, acquiring comparable private-market material before major auction benchmarks is more cost-effective than after. Auction results anchor subsequent private pricing. For buyers considering entry, the pre-September window is the relevant opportunity.

Frequently Asked Questions